Principles and indications of chronic transfusion therapy for children with sickle cell disease

Clinical Advances in Hematology and Oncology

Volumn 5, Issue 9, 2007, Pages 686-688

  Ware, Russell ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEFERASIROX; DEFEROXAMINE; HYDROXYUREA; PLACEBO; ANTISICKLING AGENT;

ACUTE CHEST SYNDROME; ARTICLE; BLOOD TRANSFUSION; BRAIN BLOOD FLOW; BRAIN INFARCTION; CEREBROVASCULAR DISEASE; CHILDHOOD DISEASE; CLINICAL TRIAL; DISEASE FREE SURVIVAL; DONOR; DOPPLER ECHOGRAPHY; ERYTHROCYTE TRANSFUSION; HIGH RISK PATIENT; HUMAN; INFERTILITY; IRON OVERLOAD; LEUKEMOGENESIS; LONG TERM CARE; MEDICAL RESEARCH; OPTIMAL DRUG DOSE; PAIN; PATIENT COMPLIANCE; PATIENT SELECTION; PHLEBOTOMY; PRIAPISM; QUALITY OF LIFE; SICKLE CELL ANEMIA; STEM CELL TRANSPLANTATION; TRANSIENT ISCHEMIC ATTACK; TREATMENT INDICATION; CHILD; FEMALE; MALE; PRESCHOOL CHILD; REVIEW;

ANEMIA, SICKLE CELL; ANTISICKLING AGENTS; BLOOD TRANSFUSION; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; HYDROXYUREA; MALE; STEM CELL TRANSPLANTATION;

EID: 38449090171     PISSN: 15430790     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (4)

1. Bernaudin F, Socie G, Kuentz M, et al. Long-term results of related, myeloablative stem cell transplantation to cure sickle cell disease. Blood. 2007 Jul 2: [Epub. ahead of print].
2. Zimmerman SA, Schultz WH, Burgett S, Mortier NA, Ware RE. Hydroxyurea therapy lowers transcranial Doppler flow velocities in children with sickle cell anemia. Blood. 2007; 110: 1043-1047.
3. Driscoll MC. Sickle cell disease. Pediatr Rev. 2007;28:219-268.
4. Vichinsky E, Onyekwere O, Porter J, et al. Deferasirox in Sickle Cell Investigators. A randomised comparison of deferasirox versus deferoxamine for the treatment of transfusional iron overload in sickle cell disease. Br J Haematol. 2007; 136: 501-508.